Dr. GPCR Podcast: Recent Episodes
Dr. Yamina Berchiche
We bring you closer to dedicated scientists who work tirelessly to help understand GPCR pathophysiology.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Read the full version of the newsletter HERE:https://www.ecosystem.drgpcr.com/dr-gpcr-newsletter/24-06-dr-gpcr-newsletter-------------------------------------------How can Users benefit Dr. GPCR Ecosystem?https://www.ecosystem.drgpcr.com/explore-individuals-------------------------------------------How can Organizations benefit from Dr. GPCR Ecosystem?https://www.ecosystem.drgpcr.com/explore-organizations-------------------------------------------Become a #DrGPCR Ecosystem Memberhttps://www.ecosystem.drgpcr.com/plans-pricing-------------------------------------------Imagine a world in which the vast majority of us are healthy.The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together. To build our #GPCR Ecosystem, we created various enabling outlets.Individualshttps://www.ecosystem.drgpcr.com/explore-individualsOrganizationshttps://www.ecosystem.drgpcr.com/explore-organizations-------------------------------------------Are you a #GPCR professional? - Subscribe to #DrGPCR monthly newsletterhttp://www.drgpcr.com/newsletter/- Listen and subscribe to #DrGPCR Podcasts http://www.drgpcr.com/podcast/- Listen and watch GPCR-focused scientific talks at #VirtualCafehttps://www.drgpcr.com/virtual-cafe/
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
To read the full #DrGPCRNewsletter click here: https://www.ecosystem.drgpcr.com/dr-gpcr-newsletter/24-03-dr-gpcr-newsletter-------------------------------------------How can Users benefit Dr. GPCR Ecosystem?https://www.ecosystem.drgpcr.com/explore-individuals-------------------------------------------How can Organizations benefit from Dr. GPCR Ecosystem?https://www.ecosystem.drgpcr.com/explore-organizations-------------------------------------------Become a #DrGPCR Ecosystem Memberhttps://www.ecosystem.drgpcr.com/plans-pricing-------------------------------------------Imagine a world in which the vast majority of us are healthy.The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together. To build our #GPCR Ecosystem, we created various enabling outlets.Individualshttps://www.ecosystem.drgpcr.com/explore-individualsOrganizationshttps://www.ecosystem.drgpcr.com/explore-organizations-------------------------------------------Are you a #GPCR professional? - Subscribe to #DrGPCR monthly newsletterhttp://www.drgpcr.com/newsletter/- Listen and subscribe to #DrGPCR Podcasts http://www.drgpcr.com/podcast/- Listen and watch GPCR-focused scientific talks at #VirtualCafehttps://www.drgpcr.com/virtual-cafe/
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
To read the full #DrGPCRNewsletter click here: https://www.ecosystem.drgpcr.com/dr-gpcr-newsletter/24-03-dr-gpcr-newsletter-------------------------------------------How can Users benefit Dr. GPCR Ecosystem?https://www.ecosystem.drgpcr.com/explore-individuals-------------------------------------------How can Organizations benefit from Dr. GPCR Ecosystem?https://www.ecosystem.drgpcr.com/explore-organizations-------------------------------------------Become a #DrGPCR Ecosystem Memberhttps://www.ecosystem.drgpcr.com/plans-pricing-------------------------------------------Imagine a world in which the vast majority of us are healthy.The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together. To build our #GPCR Ecosystem, we created various enabling outlets.Individualshttps://www.ecosystem.drgpcr.com/explore-individualsOrganizationshttps://www.ecosystem.drgpcr.com/explore-organizations-------------------------------------------Are you a #GPCR professional? - Subscribe to #DrGPCR monthly newsletterhttp://www.drgpcr.com/newsletter/- Listen and subscribe to #DrGPCR Podcasts http://www.drgpcr.com/podcast/- Listen and watch GPCR-focused scientific talks at #VirtualCafehttps://www.drgpcr.com/virtual-cafe/
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
To read the full #DrGPCRNewsletter, click here:
https://www.ecosystem.drgpcr.com/dr-gpcr-newsletter
-----
Read #ClassifiedGPCRNews here:
https://www.ecosystem.drgpcr.com/classified-gpcr-news
-----
Follow #GPCRNews to get the weekly report in your inbox:
https://www.ecosystem.drgpcr.com/profile/gpcr-news/profile
-----
How can Users benefit Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-individuals
-----
How can Organizations benefit from Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-organizations
-----
Become a #DrGPCR Ecosystem Member
https://www.ecosystem.drgpcr.com/plans-pricing
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
To read the full #DrGPCRNewsletter, click here:
https://www.ecosystem.drgpcr.com/dr-gpcr-newsletter
-----
Read #ClassifiedGPCRNews here:
https://www.ecosystem.drgpcr.com/classified-gpcr-news
-----
Follow #GPCRNews to get the weekly report in your inbox:
https://www.ecosystem.drgpcr.com/profile/gpcr-news/profile
-----
How can Users benefit Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-individuals
-----
How can Organizations benefit from Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-organizations
-----
Become a #DrGPCR Ecosystem Member
https://www.ecosystem.drgpcr.com/plans-pricing
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
To read the full #DrGPCRNewsletter, click here: https://www.ecosystem.drgpcr.com/dr-gpcr-newsletter
Read #ClassifiedGPCRNews here:
https://www.ecosystem.drgpcr.com/classified-gpcr-news
Follow #GPCRNews to get the weekly report in your inbox:
https://www.ecosystem.drgpcr.com/profile/gpcr-news/profile
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to the #DrGPCR Podcast.
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR-focused scientific talks at #VirtualCafe.
Watch the video version of this podcast episode.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #90 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #90 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #90 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #90 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #90 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #89 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #88 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #87 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #86 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #85 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #84 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #83 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #82 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
Become a #DrGPCR Ecosystem Member
For more details, visit the #DrGPCR Podcast Episode #81 page
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
Watch the video version of this podcast episode
https://www.ecosystem.drgpcr.com/dr-gpcr-podcast
Learn more about Dr. Paul Insel
https://www.ecosystem.drgpcr.com/search?q=paul+insel
How Users can benefit Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-individuals
How Organizations can benefit from Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-organizations
Become a #DrGPCR Ecosystem Member
https://www.ecosystem.drgpcr.com/plans-pricing
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
https://www.ecosystem.drgpcr.com/explore-individuals
- Organizations
https://www.ecosystem.drgpcr.com/explore-organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR monthly newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Listen and watch GPCR focused scientific talks at #VirtualCafe
https://www.drgpcr.com/virtual-cafe/
Watch the video version of this podcast episode
https://www.ecosystem.drgpcr.com/dr-gpcr-podcast
Learn more about Dr. Nicola J. Smith
https://www.ecosystem.drgpcr.com/search?q=Nicola+Smith
How Users can benefit Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-individuals
How Organizations can benefit from Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-organizations
Become a #DrGPCR Ecosystem Member
https://www.ecosystem.drgpcr.com/plans-pricing
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
https://www.ecosystem.drgpcr.com/explore-individuals
- Organizations
https://www.ecosystem.drgpcr.com/explore-organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR monthly newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Listen and watch GPCR focused scientific talks at #VirtualCafe
https://www.drgpcr.com/virtual-cafe/
Watch the video version of this podcast episode
https://www.ecosystem.drgpcr.com/dr-gpcr-podcast
Learn more about Dr. Bryan Roth
https://www.ecosystem.drgpcr.com/search?q=Bryan+Roth
How Users can benefit Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-individuals
How Organizations can benefit from Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-organizations
Become a #DrGPCR Ecosystem Member
https://www.ecosystem.drgpcr.com/plans-pricing
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
https://www.ecosystem.drgpcr.com/explore-individuals
- Organizations
https://www.ecosystem.drgpcr.com/explore-organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR monthly newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Listen and watch GPCR focused scientific talks at #VirtualCafe
https://www.drgpcr.com/virtual-cafe/
Watch the video version of this podcast episode
https://www.ecosystem.drgpcr.com/dr-gpcr-podcast
Learn more about Dr. Graciela Pineyro
https://www.ecosystem.drgpcr.com/search?q=Graciela+Pineyro
How Users can benefit Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-individuals
How Organizations can benefit from Dr. GPCR Ecosystem?
https://www.ecosystem.drgpcr.com/explore-organizations
Become a #DrGPCR Ecosystem Member
https://www.ecosystem.drgpcr.com/plans-pricing
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
https://www.ecosystem.drgpcr.com/explore-individuals
- Organizations
https://www.ecosystem.drgpcr.com/explore-organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR monthly newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Listen and watch GPCR focused scientific talks at #VirtualCafe
https://www.drgpcr.com/virtual-cafe/
For more details, visit the #DrGPCR Podcast Episode #80 page https://www.drgpcr.com/episode-80-with-andrew-tobin/
About Dr. Andrew Tobin Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining first-class honors before studying for a D.Phil at the University of Oxford. Following a post-doctoral period at Bristol Myers Squibb in Princeton USA, Andrew returned to the UK to establish his own laboratory at the University of Leicester. Funded through three consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation in the field of receptor signaling.
Now at the University of Glasgow, his primary research interests are focused on the rational design of novel drugs to treat the three global health challenges of dementia, asthma, and malaria. In this Andrew runs a research laboratory of around 15 staff supported by basic research grants investigating aspects of disease biology and the action of drugs in the context of disease. The vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd, a biotechnology company co-founded by Andrew with series A funding from the European Union.
Andrew is also the Director of the Advanced Research Centre (ARC) a collaborative initiative at the University of Glasgow underpinned by a £118M new build that will house over 550 researchers designed to drive interdisciplinary research.
Dr. Andrew Tobin on the web * University of Glasgow * ResearchGate * Google Scholar * Twitter * Dr. GPCR Ecosystem
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
For more details, visit the #DrGPCR Podcast Episode #79 page http://www.drgpcr.com/episode-79-with-graeme-milligan/
About Dr. Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and Deputy Head of the College of Medical, Veterinary, and Life Sciences at the University of Glasgow. His main research group centers on the function, structure, and regulation of G protein-coupled receptors (GPCRs) and their interacting proteins. His experience also includes translating knowledge generated into the selection of targets, screening, and identification of small molecule regulators of these proteins, and progressing such ligands in drug development programs.
Prof. Milligan has published more than 550 peer-reviewed articles and his research has been cited more than 35,000 times. He was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and to the Fellowship of the Academy of Medical Sciences in 2016.
Prof. Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for metabolic diseases including Type 2 Diabetes and other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases and Keltic Pharma Therapeutics (2020) which is developing new treatments for malaria.
Dr. Graeme Milligan on the web * University of Glasgow * ResearchGate * PubMed * Orcid * Google Scholar * LinkedIn
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
For more details, visit the #DrGPCR Podcast Episode #78 page https://www.drgpcr.com/episode-78-with-stuart-maudsley/
About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree in Pharmacology. At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. He then completed his Ph.D. at Leeds as well as the University’s Ackroyd, Brotherton, and Brown Scholar.
Following his Ph.D., Dr. Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz at Duke University. Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology Section at the Medical Research Council (MRC) -Human Reproductive Sciences Unit within the University of Edinburgh.
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional signaling. To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center. At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award, one of the few awards available within the intramural NIH program. Upon starting a new family, and returning to Europe, Dr. Maudsley continued his scientific journey with the award of the highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Sciences at the University of Antwerp.
Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases based on their gerontological underpinnings. This research stream is now forming the basis of a new technology-based start-up company, HeptOME, to help screen and develop novel longevity/disease-regulating compounds with multidimensional disease efficacy profiles.
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
For more details, visit the #DrGPCR Podcast Episode #77 page https://www.drgpcr.com/episode-77-with-Martin-Audet/
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
For more details, visit the #DrGPCR Podcast Episode #76 page https://www.drgpcr.com/episode-76-with-Steve-McCloskey/
About Steve McCloskey Steve McCloskey is an Alumni from the first class of Nanoengineering at the University of California, San Diego. Steve’s work is focused on emerging technologies applied to Science, Technology, Engineering, and Mathematics (STEM). During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center and developing thermodynamic processing methods for Iron-based Superelastic alloys. After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and Engineers working at the nanoscale, specifically protein engineering and small molecule drug development.
Steve McCloskey on the web * Website * LinkedIn * Twitter * ResearchGate * Medium * Orchid
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
To read the full #Newsletter click here:
https://www.drgpcr.com/May-2022/
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
For more details, visit the #DrGPCR Podcast Episode #75 page https://www.drgpcr.com/episode-75-with-vaithish-velazhahan/
About Vaithish Velazhahan Vaithish obtained dual bachelor’s degrees with honors in Medical Biochemistry and Microbiology from Kansas State University, USA. His undergraduate thesis work on studying the biochemical mechanisms of flavonoids in cancer using nuclear magnetic resonance spectroscopy (NMR) led to a Barry M. Goldwater Scholarship. He then received a prestigious Gates Cambridge Scholarship to study for a Ph.D. at the MRC Laboratory of Molecular Biology and the University of Cambridge, where he is currently a final year Ph.D. candidate. His Ph.D. work has been focused on understanding the structure and activation of Class D fungal GPCRs. He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination of the first structures of the prototypical fungal GPCR Ste2. This work has led to two first-authored manuscripts published in the journal Nature. Vaithish has been recognized with the MRC LMB's Max Perutz Prize for outstanding Ph.D. work and has been elected a Research Fellow at Gonville and Caius College, which is one of the most prestigious positions at the University of Cambridge.
Vaithish Velazhahan on the web * Twitter * GatesCambridge * PubMed
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
To read the full #Newsletter click here:
https://www.drgpcr.com/April-2022/
Become a #DrGPCR Ecosystem Member
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
- Individuals
- Organizations
Are you a #GPCR professional?
- Subscribe to #DrGPCR Monthly Newsletter
- Listen and subscribe to #DrGPCR Podcasts
- Listen and watch GPCR focused scientific talks at #VirtualCafe
For more details, visit the #DrGPCR Podcast Episode #74 page
http://www.drgpcr.com/episode-74-with-dr-daniel-wacker/
About Dr. Daniel Wacker I obtained my B.Sc. degree from the University of Munich performing work in the lab of Dr. Roland Beckmann with a brief stay at Cambridge University, UK, working in the lab of the late Dr. Kiyoshi Nagai. I then obtained an M.Sc. at the University in Munich working e.g. in the lab of Patrick Cramer. I next moved to Rockefeller University in NYC to work in the lab of the late Dr. Guenter Blobel, before starting my Ph.D. in 2009 at The Scripps Research Institute in La Jolla. There I obtained my Ph.D. in the lab of Dr. Ray Stevens in 2013 solving several GPCR crystal structures, including that of the first serotonin receptor. I then moved to UNC at Chapel Hill to do postdoctoral work in the lab of Dr. Bryan Roth where I established GPCR structural biology and learned the ins and outs of molecular pharmacology and in vitro drug discovery. In 2018 I started my own lab at the Icahn School of Medicine at Mount Sinai in NYC, where I have been working on structure-function and drug discovery of GPCRs and transporters.
Dr. Daniel Wacker on the web * Website * LinkedIn * Twitter * PubMed
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/
For more details, visit the #DrGPCR Podcast Episode #73 page https://www.drgpcr.com/episode-73-with-dr-aylin-hanyaloglu/
About Dr. Aylin Hanyaloglu Dr. Aylin Hanyaloglu has been a Principal Investigator at Imperial College London since 2007. She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced at the MRC Human Reproductive Sciences Centre, Edinburgh, a move to Perth, Australia resulted in her Ph.D. in Molecular Endocrinology being awarded in 2002 with Distinction from the University of Western Australia.
Dr. Hanyaloglu undertook her postdoctoral training at the University of California, San Francisco with Professor Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor trafficking and signaling.
Her research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling and receptor crosstalk, and applying these mechanisms for distinct GPCRs in diverse physiological and pathophysiological systems, with particular focus on women's health, pregnancy, and nutrient sensing in the gut. Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes UK, Wellcome Trust, and the Medical Research Council.
Dr. Aylin Hanyaloglu on the web * LinkedIn * Researchgate * Twitter * Imperial College London * Elsevier * Loop
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
For more details, visit the #DrGPCR Podcast Episode #72 page https://www.drgpcr.com/episode-72-with-stuart-maudsley/
About Dr. Stuart Maudsley
Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree in Pharmacology. At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. He then completed his Ph.D. at Leeds as well as the University’s Ackroyd, Brotherton, and Brown Scholar.
Following his Ph.D., Dr. Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz at Duke University. Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology Section at the Medical Research Council (MRC) -Human Reproductive Sciences Unit within the University of Edinburgh.
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional signaling. To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center. At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award, one of the few awards available within the intramural NIH program. Upon starting a new family, and returning to Europe, Dr. Maudsley continued his scientific journey with the award of the highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Sciences at the University of Antwerp.
Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases based on their gerontological underpinnings. This research stream is now forming the basis of a new technology-based start-up company, HeptOME, to help screen and develop novel longevity/disease-regulating compounds with multidimensional disease efficacy profiles.
Dr. Stuart Maudsley on the web * Maudsley Lab * LinkedIn * Google Scholar * ResearchGate * Maudsley Lab on Facebook * Receptor Biology Lab Facebook Group * Twitter * Semantic Scholar * Instagram * Neurotree * Dimensions * Reddit
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
For more details, visit the #DrGPCR Podcast Episode #71 page https://www.drgpcr.com/episode-71-with-dr-jean-martin-beaulieu
About Dr. Jean Martin Beaulieu Dr. Beaulieu received a Ph.D. in Neurological Sciences from McGill University and completed his post-doctoral training at Duke University. Prior to his recruitment Dr. Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry and Neuroscience at Laval University.
Dr. Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive drugs intersect with genetic risk factors for mental illnesses such as schizophrenia, depression, and bipolar disorder. Dr. Beaulieu has pioneered work establishing a role for Beta-arrestin signaling in the brain in vivo and has established its importance in D2 dopamine receptors (D2R) functions. These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular target for drug development. In particular, D2R is the main pharmacological target of antipsychotic drugs prescribed for schizophrenia and bipolar disorders. Work by the Beaulieu Lab has demonstrated that mood stabilizer drugs (e.g. lithium) used for bipolar disorder therapy target signaling mechanisms regulated by dopamine receptors, thus providing a framework to understand how different drug classes can engage overlapping cellular mechanisms to exert their action. The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric modulators of D2R signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical agents.
Translational validation is important to validate findings obtained from experimental models research and bridge the gap between bench and bedside. Working in collaboration with geneticists, the Beaulieu-Lab has identified interactions between cellular mechanisms engaged by D2R and psychiatric drugs with genetic risk factors implicated in schizophrenia by large whole-genome association studies (GWAS) in humans. These investigations have led to the identification of an RNA binding protein (FXR1P) involved in the regulation of protein synthesis as a potential downstream effector of the action of mood stabilizers and other psychoactive drugs.
In addition to basic research, the Beaulieu group is also actively implicated in translational research and industry collaboration to develop new drugs and drug development technology.
Dr. Jean Martin Beaulieu on the web * University of Toronto * Google Scholar * LinkedIn * ResearchGate
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
For more details, visit the #DrGPCR Podcast Episode #70 page https://www.drgpcr.com/episode-70-with-dr-stephen-ferguson/
About Dr. Stephen Ferguson Dr. Stephen Ferguson is a Professor in the Department of Cellular and Molecular Medicine at the University of Ottawa. He did B.Sc. in biology at McGill University and received his Ph.D. under the mentorship of Dr. Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
He did his postdoctoral training with Dr. Marc G. Caron at Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling. He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator (2003-2016).
He was a recipient of Canada's Top 40 under 40 award in 2004 and received Queen Elizabeth II, Diamond Jubilee Medal, in 2012. He has also received both Junior (2001) and Senior (2005) investigator awards from the Pharmacological Society of Canada. Most recently, in 2021, he was elected as a Fellow of the Canadian Academy of Health Science (FCAHS). His research career has focused on the investigation of the regulation of G protein-coupled receptors signaling mechanisms in health and disease. He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Alzheimer’s disease.
Dr. Stephen Ferguson on the web * Carlton University * Canada Research Chairs * Twitter * ResearchGate * LinkedIn
Great Lakes GPCR Retreat on the web * 21st Great Lakes GPCR Retreat * More about previous GPCR Retreat meetings
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
For more details, visit the #DrGPCR Podcast Episode #69 page http://www.drgpcr.com/episode-69-history-of-the-gpcr-retreat-with-dr-stephen-ferguson/
About Dr. Stephen Ferguson Dr. Stephen Ferguson is a Professor in the Department of Cellular and Molecular Medicine at the University of Ottawa. He did B.Sc. in biology at McGill University and received his Ph.D. under the mentorship of Dr. Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
He did his postdoctoral training with Dr. Marc G. Caron at Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling. He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator (2003-2016).
He was a recipient of Canada's Top 40 under 40 award in 2004 and received Queen Elizabeth II, Diamond Jubilee Medal, in 2012. He has also received both Junior (2001) and Senior (2005) investigator awards from the Pharmacological Society of Canada. Most recently, in 2021, he was elected as a Fellow of the Canadian Academy of Health Science (FCAHS). His research career has focused on the investigation of the regulation of G protein-coupled receptors signaling mechanisms in health and disease. He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Alzheimer’s disease.
Dr. Stephen Ferguson on the web * Carlton University * Canada Research Chairs * Twitter * ResearchGate * LinkedIn
Great Lakes GPCR Retreat on the web
- 21st Great Lakes GPCR Retreat
- More about previous GPCR Retreat meetings
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
For more details, visit #DrGPCR Podcast Episode #68 page https://www.drgpcr.com/episode-68-with-dr-matthew-eddy/
About Dr. Matthew Eddy
Matthew Eddy earned his BA in Chemistry from Oberlin College, where he trained with solid-state NMR expert Professor Manish Mehta. He then earned his Ph.D. in physical chemistry from the Massachusetts Institute of Technology, training under the mentorship of Prof. Robert Griffin. Following this, Dr. Eddy began learning and investigating human GPCRs while training in the laboratories of Professors Raymond Stevens and Kurt Wüthrich at The Scripps Research Institute.
Dr. Matthew Eddy on the web * Website
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
For more details, visit #DrGPCR Podcast Episode #67 page https://www.drgpcr.com/episode-67-with-graham-ladds/
About Dr. Graham Ladds
Graham studied Biochemistry at the University of Birmingham before completing a Ph.D. in yeast pheromone signaling at Warwick. He continued to work at Warwick as a post-doc studying pro-hormone convertases before securing a 5-year independent fellowship funded through the NHS. This project enabled him to return to his interest in GPCRs.
He progressed through the ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology at Cambridge, where he is also a Fellow of St John’s College. In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society.
His research group uses a combination of pharmacological investigations and mathematical modeling to study factors that control agonist bias at GPCRs. These investigations have enabled him to foster strong collaborations with the pharmaceutical industry (GSK, Takada, and Firmenich) which have recently been enhanced through him being awarded a Royal Society Industry Fellowship to collaborate with AstraZeneca.
Dr. Graham Ladds on the web * Twitter * ResearchGate * LinkedIn * Google Scholar * PubMed
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
Dr. Antony A. Boucard Jr. on the web Website LinkedIn Researchgate Loop Academia Pubmed Adhesion GPCR Consortium University of Haiti
For more details, visit #DrGPCR Podcast Episode #66 page https://www.drgpcr.com/episode-66-with-antony-a-boucard-jr/
About Dr. Antony A. Boucard Jr.
Dr. Antony Boucard joined the Université de Sherbrooke (Québec, Canada) as a B.S. student of the Biochemistry program in 1994 from which he graduated in 1997. It is then that his interest bloomed for the study of GPCRs while joining the group of Dr. Richard Leduc and Dr. Gaetan Guillemette in the Pharmacology department at the Université de Sherbrooke. He completed a master’s degree in 2000 and a Ph.D. degree in 2003 with a particular interest in the cardiovascular system by investigating the structure of the Angiotensin and Urotensin receptors through various biochemical approaches centered in the elucidation of ligand binding pocket determinants...
Dr. Antony A. Boucard Jr. on the web
- Website
- Researchgate
- Loop
- Academia
- Pubmed
- Adhesion GPCR Consortium
- University of Haiti
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
For more details, visit #DrGPCR Podcast Episode #65 page https://www.drgpcr.com/episode-65-with-sudarshan-rajagopal/
About Dr. Sudarshan Rajagopal Dr. Sudarshan Rajagopal obtained his B.S. in Chemistry from The University of Chicago in 1998. He subsequently enrolled in the Medical Scientist Training Program at The University of Chicago. During his doctoral work in the lab of Prof. Keith Moffat, he studied the structural mechanisms of bacterial photoreceptors using time-resolved Laue crystallography. He was awarded his Ph.D. in 2004 and his MD in 2006. He then joined the Internal Medicine Residency training program at Duke University Medical Center. During his Cardiology fellowship, he trained in the lab of Dr. Robert J. Lefkowitz, where his research focused on biased agonism, with the development of approaches to quantify ligand bias and the identification of beta-arrestin-biased receptors.
After completing his training in clinical cardiology, he started as an Assistant Professor of Medicine at Duke University School of Medicine. The main focus of his lab’s research is on the mechanisms underlying biased agonism at chemokine receptors and how that contributes to inflammation. The chemokine system is relatively unique in having multiple receptors and multiple ligands that display considerable promiscuity for one another. His group and others have shown that many of these ligands act as biased agonists for the same receptor. His lab is also interested in identifying novel signal transduction mechanisms of GPCRs, such as the formation of complexes between G proteins and beta-arrestins. His clinical focus is on pulmonary arterial hypertension, a disease of the pulmonary arterioles that causes right heart failure, and he serves as co-director of the Duke Pulmonary Vascular Disease Center.
Dr. Sudarshan Rajagopal on the web * LinkedIn * Website * Google Scholar * LinkedIn
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Share your feedback with us:
http://w
To read the full #Newsletter click here:
https://www.drgpcr.com/march-2022/
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
For more details, visit #DrGPCR Podcast Episode #64 page https://www.drgpcr.com/episode-64-with-dr-dylan-eiger/
About Dylan Eiger
Dylan Eiger is currently an MD/Ph.D. student at Duke University School of Medicine. He received his B.S. in Chemistry from Duke University in 2016 where he worked in the lab of Dr. Stephen Craig and studied polymer chemistry and material science.
He is currently finishing his Ph.D. in the lab of Dr. Sudarshan Rajagopal, a former postdoctoral fellow of Dr. Robert J. Lefkowitz. Dylan's graduate research focuses on the mechanisms underlying biased signaling at GPCRs, specifically, the role of differential receptor phosphorylation (phosphorylation barcodes) and subcellular GPCR signaling in directing functionally selective responses. He primarily studies the chemokine receptor CXCR3 as it has three naturally occurring ligands and thus serves as an endogenous example of biased agonism.
After finishing his MD/Ph.D., Dylan plans to complete his residency training in Internal Medicine and subsequently pursue fellowship training in Cardiology. He hopes to continue his research on biased agonism at GPCRs with a particular focus on the treatment of cardiovascular disease.
Dylan Eiger on the web * LinkedIn * Twitter * PubMed * Website
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
For more details, visit #DrGPCR Podcast Episode #63 page https://www.drgpcr.com/episode-63-with-dr-khaled-abdelrahman/
Dr. Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology in the same university that was conferred in 2009. He joined the laboratory of Dr. William Cole at the University of Calgary in 2010 for his Ph.D. where he studied the molecular basis underlying altered cerebrovascular function and blood flow in type 2 diabetes. In 2015, He joined Dr. Stephen Ferguson’s laboratory in the Departments of Cellular & Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically to slow neurodegeneration. He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area of neurodegenerative diseases.
He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral Fellowships offered by Alberta Innovates and Canadian Institutes of Health Research. He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
To read the full #Newsletter click here:
http://www.drgpcr.com/february-2022/
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
For more details, visit #DrGPCR Episode #62 page
https://www.drgpcr.com/episode-62-with-dr-sai-prasad-pydi/
About Dr. Sai Prasad Pydi
Dr. Sai Prasad Pydi obtained his Ph.D. from the University of Manitoba – Canada, where he was introduced to G protein-coupled receptors (GPCRs) by Prof. Prashen Chelikani. His doctoral research focused on the structural and functional characterization of bitter taste receptors (T2Rs). In 2014, Dr. Pydi joined Dr. Jurgen Wess’s lab at the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) - NIH, USA as a postdoctoral fellow and trained on understanding the physiological role of GPCR signaling and beta-arrestins in diabetes and obesity. In February 2021, Dr. Pydi joined BSBE department at IIT-Kanpur. The main target of Dr. Pydi's laboratory is to develop GPCR-based drugs for the treatment of obesity and Type 2 Diabetes (T2D) by exploring metabolically important signaling pathways in immune cells and insulin-sensitive tissues (liver, pancreas, skeletal muscle, adipose tissue, and brain). His laboratory uses knock-out and transgenic mouse models, along with different cell culture systems, to understand the role of immune cell GPCRs and their cross-talk with other insulin-sensitive tissues regulating glucose and lipid metabolism.
Dr. Sai Prasad Pydi on the web
Molecular Metabolism & Cell Signaling Laboratory
https://www.mmcsliitk.in/
Website
https://www.iitk.ac.in/bsbe/sai-prasad-pydi
https://twitter.com/saip_pydi
Research Gate
https://www.researchgate.net/profile/Sai-Prasad-Pydi
PubMed
https://pubmed.ncbi.nlm.nih.gov/?term=pydi%20SP
Google Scholar
https://scholar.google.com/citations?user=VLWGR5gAAAAJ&hl=en
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
For more details, visit #DrGPCR Podcast Episode #61 page https://www.drgpcr.com/episode-61-with-dr-marta-filizola/
About Dr. Marta Filizola
Dr. Marta Filizola is the Sharon & Frederick A. Klingenstein-Nathan G. Kase, MD Professor in the Departments of Pharmacological Sciences, Neuroscience, and Artificial Intelligence and Human Health, as well as the Dean of The Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai, in New York, USA. The overall goal of her research program is to obtain rigorous mechanistic insights into the structure, dynamics, and function of important classes of membrane proteins and prominent drug targets, including G protein-coupled receptors (GPCRs), transporters, channels, and 3 integrins. To this end, her lab uses several computational structural biology tools and rational drug design approaches, ranging from molecular modeling, bioinformatics, cheminformatics, molecular dynamics simulations, free-energy perturbations, machine learning, etc. A native of Italy, she received her Bachelor’s and Master’s degrees in Chemistry from the University Federico II in Naples. She pursued a Ph.D. in Computational Chemistry at the Second University of Naples and a postdoctorate in Computational Biophysics at the Molecular Research Institute in California, USA.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
For more details, visit #DrGPCR Podcast Episode #60 page
https://www.drgpcr.com/episode-60-with-dr-josephine-pina-cardarelli/
About Dr. Josephine (Pina) Cardarelli
Dr. Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area. The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers of G protein-coupled receptors (GPCR). Burixafor, their most advanced clinical candidate, will be in Phase II clinical trial next year. Additionally, they have a library of target GPCR heteromers for Oncology. Dr. Cardarelli heads the team of talented researchers that will be expanding at the US site.
Dr. Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing biologics to clinical proof of concepts. She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology, and clinical development. Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers Squibb. She was an integral contributor to two therapeutics that are FDA approved, Yervoy and Opdivo. She was a participant in numerous due diligence (anti-CXCL8 mAb) and has managed external collaborations and alliances. Prior to this, she held the position of Vice President, at Medarex, Inc. While at BMS and Medarex, she led programs from target ID to clinical development that included, CXCL10 (Eldelumab), CXCR4 (Ulocuplumab), CD30, CD19, Fucosyl GM-1, & mesothelin-ADC, Glypican-3-ADC, CD70-ADC.
She oversaw early discovery programs IL-23 p19 and IL23 p19/IL-17 bispecifics. At Medarex, she initiated and identified the lead mAb for the type I interferon-alpha receptor project, licensed to AstraZeneca (Saphnelo™ Anifrolumab) that has just received FDA approval for systemic lupus erythematosus. She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience in IND fillings, IB updates, and responding to FDA inquiries. She is an inventor on 39 issued U.S. patents including anti-PD-1 patents, 22 EP patents, and greater than 100 global patents centered around therapeutic development. She has also authored forty-six peer-reviewed publications. Dr. Cardarelli received her Ph.D. in Physiology from Albany Medical College.
Dr. Josephine (Pina) Cardarelli on the web
https://www.linkedin.com/in/josephine-pina-cardarelli/
Website
http://gpcr.co.kr/
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
To read the full #Newsletter click here:
https://www.drgpcr.com/january-2022/
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
For more details, visit #DrGPCPodcast Episode #59 page
https://www.drgpcr.com/episode-59-with-nicola-j-smith/
About Dr. Nicola J. Smith
Dr. Nicola J Smith is an expert in molecular pharmacology with a track record in exploring GPCR structure-function relationships in the context of cardiovascular disease and metabolic disorders. She is a National Heart Foundation of Australia Future Leader Fellow and runs a laboratory of 7 Ph.D. and Honours students at UNSW Sydney, where she has recently been promoted to Associate Professor. Most recently, Dr. Smith’s team has made advances in the understanding of how an orphan GPCR exerts its effects both in vitro (cell culture and ex vivo models) and in vivo (measures of physiological and pathological cardiometabolic function in unconscious and conscious mice). Together with Irina Kufareva, UCSD, her team developed a novel approach to identifying ligands for orphan GPCRs by developing a powerful new computational tool for identifying ‘surrogate’ ligands (borrowed from other receptors) for orphan GPCRs, named GPCR-CoINPocket. Her career goal is to leverage this expertise to establish a research program that takes orphan GPCRs from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic targets with high-affinity ligands.
Dr. Nicola J. Smith on the web
UNSW Sydney
https://med.unsw.edu.au/our-people/nicola-smith
https://med.unsw.edu.au/our-people/nicola-smith
Retraction Watch
https://retractionwatch.com/2021/01/12/the-most-horrific-time-of-my-career/
Retraction Watch
https://retractionwatch.com/2021/01/12/the-most-horrific-time-of-my-career/Twitter
https://twitter.com/smith_orphans
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
For more details, visit #DrGPCRPodcast Episode #58 page https://www.drgpcr.com/episode-58-with-juan-jose-fung/ ------------------------------------------- About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc, a drug discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&D facility in the SF Bay Area. Dr. Fung received his Ph.D. from the Stanford University School of Medicine under the mentorship of Dr. Brian Kobilka, studying the dimerization of GPCRs. Dr. Fung continued his Postdoctoral training in Dr. Kobilka’s lab contributing to the elucidation of high-resolution structures of various GPCRs. Dr. Fung has spent significant time in the industry studying membrane proteins, antibodies, and HTS methods for drug discovery. His current work is mainly focused on screening and assay development to bridge the gap between in vitro and in vivo GPCR pharmacology.
Dr. Juan José Fung on the web * LinkedIn * Website
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
For more details, visit #DrGPCR Podcast Episode #55 page https://www.drgpcr.com/episode-55-with-dr-mark-schmeizl/
About Mark Schmeizl Mark leverages 30 years in various life science laboratories & commercial roles with his network of VC & PE contacts to help senior-level life science executives identify new opportunities. He has successfully built numerous global life science, leadership teams, & works closely with both clients & candidates to understand their unique needs & culture. Mark believes professional placement should be about matching talented people with companies where they will thrive, “when the match is right, the results are astonishing.”
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
To read the full #Newsletter click here:
https://www.drgpcr.com/december-2021/
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
To read the full #Newsletter click here:
https://www.drgpcr.com/november-2021/
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
For more details, visit #DrGPCR Podcast Episode #57 page:
https://www.drgpcr.com/episode-57-with-dr-peter-robert-banks/
About Dr. Peter Robert Banks Peter Banks is currently the Scientific Director at BioTek Instruments, now a part of Agilent. His responsibilities include the management of the company’s applications team and providing scientific guidance to the senior management team on new technology and emerging trends impacting life sciences. Before joining BioTek in 2008, Banks was employed by PerkinElmer for a decade. These roles included management of PerkinElmer’s BioPharma R&D program and Chair of the company’s Scientific Advisory Board. Prior to experiences at PerkinElmer and BioTek, Banks was an Assistant Professor in Analytical Chemistry at Concordia University, Montreal, Canada from 1994 to 1998.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
For more details, visit #DrGPCR Podcast Episode #56 page:
http://www.drgpcr.com/episode-56-with-dr-adriano-marchese/
Adriano Marchese is a Professor of Biochemistry at the Medical College of Wisconsin. Adriano received his Bachelor of Science degree in Pharmacology in 1991 from the University of Toronto. He continued his graduate studies at the University of Toronto where he earned his MSc (1994) and Ph.D. (1998) in Pharmacology. He then moved to Thomas Jefferson University in Philadelphia, PA, for his postdoctoral training in Jeff Benovic’s laboratory studying the regulation of G protein-coupled receptor trafficking and signaling. In 2004 Adriano joined the faculty of the Department of Pharmacology at Loyola University Chicago. In 2016 he decided to move his lab to the Medical College of Wisconsin in Milwaukee, WI.
Adriano’s research has contributed to our understanding of the role that ubiquitin plays in GPCR signaling and trafficking. His laboratory is interested in understanding the mechanisms that govern spatial and temporal regulation of GPCR signaling by -arrestins and post-translational modifications (PTMs), such as phosphorylation, ubiquitination, and SUMOylation. His lab has shown a role for -arrestins and PTMs in GPCR trafficking and signaling and has leveraged this knowledge to reveal the spatial and temporal requirements for GPCR activation of signaling pathways related to cell survival, proliferation, and migration. The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic development.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
About Dr. JoAnn Trejo Dr. JoAnn Trejo earned her Ph.D. at UC San Diego. She completed her postdoctoral fellowship at UC San Francisco under the guidance of Professor Shaun Coughlin where she worked on the newly discovered protease-activated GPCRs. Dr. Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly rose through the ranks to tenured professor in 2012. In 2014, she was appointed Vice-Chair of the Department of Pharmacology.
The long-term goal of Dr. Trejo’s research program is to gain a thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer progression. PARs are GPCRs that are activated through an atypical irreversible proteolytic mechanism. The precise control of PAR signaling is critical for proper temporal and spatial dynamics of signaling and appropriate cellular responses. Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR biology and for the identification of drug targets and future drug development. Dr. Trejo’s research has focused on PAR1, which has important functions in hemostasis, thrombosis, inflammation, and cancer and is an important drug target. She has made numerous important discoveries related to the mechanisms that control PAR1 signaling and closely related family members and published extensively on this topic. Dr. Trejo has been continuously funded by the NIH for >20 years and was a recipient of the prestigious American Heart Association Established Investigator Award. Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over the years she has discovered novel aspects of GPCR biology, acquired critical expertise, and rigorous approaches to examine PAR1 function using human cultured cells and mouse models. Dr. Trejo has presented her studies at 52 national/international meetings and 66 academic seminars across the U.S.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- &
To read the full #Newsletter click here:
https://www.drgpcr.com/october-2021/
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
About Dr. Timo De Groof Dr. Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in 2015. During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry. During his last year of studies, Timo performed research in the biopharmaceutical company Argen x and gained experience in the identification and characterization of llama-derived antibodies in inflammatory diseases and oncology.
From 2015 to 2019, he completed his Ph.D. in the Medicinal Chemistry group at VU University Amsterdam under the supervision of prof. dr. Martine Smit. During his Ph.D., Timo, together with Dr. Raimond Heukers, developed a nanobody platform within the research group and used this platform to develop nanobodies targeting viral G protein-coupled receptors with a special focus on the human cytomegalovirus-encoded chemokine receptor US28. During his Ph.D., he used these nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic potential in oncology and transplant infectious disease.
Starting from September 2019, Timo started working as a postdoctoral researcher at the Vrije Universiteit Brussel in the In Vivo Cellular and Molecular Imaging (ICMI) group that is focused on translational/clinical applications of nanobodies. He currently is focusing on the development of nanobody-based immunotracers as part of the IMI/EFPIA project entitled "Immune Image". Moreover, he is closely involved in multiple projects where he focuses on the generation of nanobodies against "difficult-to-target" proteins. In the near future, Timo hopes to combine his previous GPCR experience with his current focus to set up his own research line focusing on translational applications of GPCR-targeting nanobodies.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
About Dr. Benjamin Myers Ben Myers is an assistant professor at the University of Utah School of Medicine in Salt Lake City, UT, and an investigator with the Huntsman Cancer Institute. Ben’s research focuses on Smoothened and other class F GPCRs which play essential roles in embryonic development and in cancer. His group studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models. These studies have revealed new and unexpected ways for membrane lipids to regulate GPCR activity and for GPCRs to control intracellular kinases. More recently, Ben’s lab has begun studying GPCR signaling pathways that operate within the primary cilium, a tiny antenna-shaped structure at the cell surface with critical links to development, physiology, and disease.
Ben studied developmental and cancer signaling as a postdoctoral fellow with Philip Beachy at Stanford University. Prior to that, Ben received his Ph.D. from UCSF in 2008, where he worked with David Julius on the structure, function, and physiology of ion channels and GPCRs in the nervous system.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
Undergraduate BSc with Honours in Pharmacology from University of Sydney (1987, snake neurotoxins), Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin, sigma receptors). Postdoc with Graeme Henderson (Bristol, opioids and Ca signaling) and Mac Christie (Sydney, opioids in neurons, novel spider toxins). Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009, appointed Professor of Pharmacology at Macquarie University. Focus on study of drugs and toxins on GPCR (opioid, cannabinoid receptor) and ion channel (K, Ca, TRP channel) function; mostly electrophysiology and fluorescence-based reporters, but can grind and bind. Currently pursuing molecular pharmacology of phytocannabinoids and novel synthetic cannabinoids, with a focus on efficacy and novel targets. Interested in orthosteric and allosteric interactions, and still looking for some bias ... anywhere ... these days human only.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
To read the full #Newsletter click here:
https://www.drgpcr.com/september-2021/
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Tom Sakmar is a physician-scientist and Rockefeller University professor dedicated to drug discovery and chemical biology research, mainly involving GPCRs. He and his artist/designer wife, Karina Åberg, have three teenage children.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
About Dr. Sudha Shenoy Dr. Sudha Shenoy is currently an Associate Professor in Medicine & Cell Biology in the Division of Cardiovascular Medicine, Duke University Medical Center. She received her Ph.D. from Oklahoma State University and completed her postdoctoral training with Dr. Robert J. Lefkowitz (Nobel Laureate, 2012) at Duke University. Dr. Shenoy’s postdoctoral research discovered that ubiquitination of mammalian G protein-coupled receptors is a tag for lysosomal degradation, whereas ubiquitination of the adaptor protein, β-arrestin, is a tag for receptor internalization and formation of signaling endosomes. Her laboratory has continued to work on identifying the molecular mechanisms that ascribe ubiquitin code on GPCRs and β-arrestins. Current efforts aim to understand the regulation of GPCR and beta-arrestin signaling in the heart and vascular endothelium by the deubiquitinating enzymes USP20 and USP33.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
About Dr. Nyla Naim Nyla is a Senior Scientist on the Scientific Support Team at Addgene. She received her Ph.D. at the University of Pittsburgh and continued her postdoctoral research at the University of Vermont studying cellular signaling, biosensors, and optogenetics. Nyla supports biomedical research by connecting researchers with resources and promoting reproducible science.
About Dr. Michael Lemieux
''My name is Michael (Mike) Lemieux and I am a Connecticut native. I completed my Ph.D. in molecular and cell biology at UConn and then joined Addgene as a Quality Control Scientist in 2015. Since then I transitioned into a Scientific Support role to leverage my passion for helping people! Beyond my interest in science, I am a strong advocate for graduate education reform and I love to write.''
About Dr. Jason Nasse Dr. Jason Nasse is a senior scientist at Addgene specializing in the use of AAV viral vectors. He obtained his Ph.D. in Neuroscience from Ohio State University focusing on synaptic plasticity and adrenergic receptor modulation of both pre-and postsynaptic properties. By taking a very non-traditional path to obtain a Ph.D. Dr. Nasse has had the opportunity to experience how science is performed across different sectors and around the country. Prior to his role at Addgene, Jason held roles in academia, big pharma, and non-profit research organizations.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.yo&a
About Dr. Simone Prömel Simone Prömel is currently a professor of cell biology at the Heinrich Heine University Düsseldorf, Germany. Being a biochemist by training, she completed her Ph.D. at the Institute of Biochemistry at the University of Oxford, UK. During this time, she discovered her love for Adhesion GPCRs and started delineating the molecular mechanisms of the Adhesion GPCR Latrophilin-1.
These extraordinary receptors, about which there was not much known other than that they are huge and somehow play important roles in health and disease, fascinated her so much that she continued working on them when she started her own lab at Leipzig University. There she focused on the different modes of action of Adhesion GPCRs and found that they do not only mediate classical G protein signals into cells but can also communicate solely via their N termini.
Today, she and her team are working on the questions of how Adhesion GPCRs integrate the different signals on a molecular level and how these are translated into physiological functions in various model organisms. Together with Ines Liebscher, Simone is leading an EU-funded COST Network on Adhesion GPCRs: CA18240 Adher´n Rise.
About Dr. Ines Liebscher
Dr. Liebscher is a Professor at the Rudolf Schönheimer Institute of Biochemistry at the Medical Faculty of the Leipzig University. During her medical studies in Leipzig, she had her first encounter with an orphan GPCR as the subject of her MD thesis. Being faced with the vast unknown biochemical and pharmacological territory that would be helpful to study orphan receptors she enrolled in the MD/Ph.D. program of Leipzig University. Her postdoctoral work leads her to investigate a whole family of orphan receptors: adhesion GPCRs.
With the little knowledge on these receptors available, there were multiple questions to tackle. Starting with proving and characterizing G-protein coupling, Ines spends several years studying the activation mechanism of adhesion GPCRs. In collaboration with great fellow adhesion GPCR scientists around the globe she established a tethered agonist -extracellular matrix- mechano-activation- activation scenario that forms the basis for her current projects that focus on the structural and physiological implications of these findings. Together with Simone Prömel, Ines is leading a COST Network on adhesion GPCRs: CA18240 Adher'nRise.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.yo&a
Gunnar Schulte is a Professor in receptor pharmacology and research group leader for the section Receptor Biology and Signaling at the Department of Physiology and Pharmacology. He has a background in biochemistry from the Free University in Berlin/Germany and a Ph.D. in molecular pharmacology (supervisor: Bertil B Fredholm; 1998-2002) from Karolinska Institutet. As a postdoc, he trained first with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology; 2003-2005) and later with Roger J Summers (Monash University, Melbourne Australia, GPCR pharmacology; 2006) before starting his independent research team "Receptor Biology & Signalling" in 2008. Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and a member of the editorial board/editorial advisory board of Molecular Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological Chemistry.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
''Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from the University of Braunschweig, Germany. For postdoctoral training, he joined the laboratory of Dr. AD Strosberg in France, where he worked on the regulation of ß-adrenergic receptors. He is the Research director at INSERM with a specific interest in G protein-coupled receptors by developing original BRET and TR-FRET assays. His laboratory is currently located at the Institute Cochin – Inserm (Paris, France).
He was the director of the French network of GPCRs (GDR-3545), currently directs the International Research Network (IRN) i-GPCRnet of the CNRS, is chair of IUPHAR « Melatonin receptor » sub-committee, Editor-in-Chief of « Frontiers in Cellular Endocrinology » and AE of « J Pineal Research”. He is a highly cited researcher – 2019 and 2020 identified by Clarivate Web of Science ™.''
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Steve Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to GSK from 1986 to 2008. He introduced molecular pharmacology to a wide range of the companies GPCR projects and was able to initiate some projects. These included the identification of RAMPs (solving some CGRP family issues) and the GABA B, carboxylic and nicotinic acid receptors. He also discovered and championed a novel prostaglandin EP4 drug candidate to development. He finished his career as Head of Bioinformatics for Neuroscience and working on GSKs novel genetics initiative
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Randy Hall, Ph.D., is a Professor of Pharmacology and Chemical Biology in the Emory University School of Medicine. Randy received his Bachelor's degree in 1990 from the University of New Hampshire and attended graduate school at the University of California at Irvine, studying the regulation of ionotropic glutamate receptors under the direction of Gary Lynch. After obtaining his Ph.D. in 1994, Randy moved to the Vollum Institute in Portland, Oregon, to do a post-doctoral fellowship in the laboratory of Thomas Soderling studying glutamate receptor trafficking and phosphorylation.
In 1996, Randy continued his post-doctoral training at Duke University, where he studied the regulation of adrenergic receptors in the laboratory of Nobel Laureate Robert Lefkowitz. Randy then joined the faculty at the Emory University School of Medicine in 1999. Over the past two decades, his lab has published numerous groundbreaking findings shedding light on the signaling and regulation of GPCRs from the adrenergic, purinergic, glutamatergic, GABAergic, and adhesion sub-families. Most recently, his lab has made a number of seminal contributions to understanding the signaling, regulation and in vivo actions of the neuroprotective receptors GPR37 & GPR37L1 as well as the adhesion GPCRs BAI1, BAI2, and GPR56. Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb receptor signaling and/or trafficking.
Visit the podcast page to read more about Randy.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree in Pharmacology. At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. He then completed his Ph.D. at Leeds as well as the University’s Ackroyd, Brotherton, and Brown Scholar.
Following his Ph.D., Dr. Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz at Duke University. Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology Section at the Medical Research Council (MRC) -Human Reproductive Sciences Unit within the University of Edinburgh. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional signaling. To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center. At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award, one of the few awards available within the intramural NIH program. Upon starting a new family, and returning to Europe, Dr. Maudsley continued his scientific journey with the award of the highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Sciences at the University of Antwerp.
Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases based on their gerontological underpinnings. This research stream is now forming the basis of a new technology-based start-up company, HeptOME, to help screen and develop novel longevity/disease-regulating compounds with multidimensional disease efficacy profiles.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
After obtaining a BSc in chemistry at the University of Alberta in Edmonton Canada, Terry received his Ph.D. in Pharmacology from the University of Alberta, Department of Chemistry, Canada. Dr. Kenakin then moved to the UK, where he did a post-doctoral fellowship in University College London with Sir James Black.
His next stop took him to Burroughs-Wellcome (BW) in Research Triangle Park (RTP) in North Carolina USA. After 7 years at BW, Dr. Kenakin joined Glaxo Inc in RTP where he remained for 25 years through iterations of Glaxo Inc, GlaxoWellcome, and finally GlaxoSmithKline.
Since 2011, Terry works at the Department of Pharmacology at the University of North Carolina School of Medicine Chapel Hill NC. His interests are in receptor pharmacology, allosteric protein function, and drug discovery.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Dr. Bender completed his undergraduate studies at Colgate University in upstate New York with a degree in Biochemistry. Between undergraduate and graduate school Brian worked as a technician in an academic lab before moving to Nashville, TN for graduate work at Vanderbilt University where he joined the Department of Pharmacology. Brain’s work there primarily focused on structure prediction of GPCRs from sparse experimental data. He then moved to the University of California in San Francisco to continue his training as a postdoctoral researcher where he used structural models of GPCRs to virtually screen large compound libraries with the goal of finding new chemical matter to probe understudied and orphan receptors.
Brian is involved in organizing the GRC/GRS Molecular Pharmacology meeting, which has been postponed to 2023. Brian is one of the organizers of the upcoming Transatlantic ECI GPCR Symposium.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Dr. Kathryn E Livingston is currently a Product Manager at Gator Bio, a biotechnology company providing solutions to researchers studying protein-protein interactions. Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in Pharmacology at the University of Michigan. Working under the supervision of Dr. John Traynor, Kathryn worked to develop and understand first-in-class allosteric modulators of opioid receptors. Research into their mechanism of action in purified systems formed the base of her thesis work. Following this, Kathryn did a post-doctoral fellowship at UCSF in the laboratory of Dr. Mark von Zastrow. There she researched the beta-2 adrenergic receptor and developed assays to investigate real-time activity in intact cellular systems. Kathryn’s passion is developing solutions to problems in whatever form is most efficient: novel instrumentation, novel methods, or novel communication.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Alexander is currently a postdoc as a member of the personalized medicine cluster in Copenhagen and at the Institute of Biological Psychiatry in Roskilde working with the UK Biobank and other large-scale population cohorts.
Alexander has a big interest in the integration of large biomedical data in genomics, structural biology, pharmacology, and pharmacoepidemiology with innovative computational methods to gain novel insights into receptor biology.
During his Ph.D. with David Gloriam at the Department of Drug Design and Pharmacology in Copenhagen, he worked on novel analytical methods to identify human signaling systems and thereby discovered endogenous peptides activating several orphan receptors. Alexander had a research sabbatical with Madan Babu at the MRC Laboratory of Molecular Biology in Cambridge, UK, where he was working on the impact of genetic variations on drug response. He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D. Award” for his work on GPCRs.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors, from the University of Kent, United Kingdom. He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class B GPCRs as part of his postdoctoral training.
Today, Sam is a pharmacology data analyst and the founder of Pharmechanics LLC, a consultancy and data analysis company supporting pharmaceutical, life science, and academic scientists in the development of new therapeutics and the understanding of receptor systems. As an industry pharmacologist, he consults with numerous pharma and biotechs in understanding and applying in vitro pharmacology data to advance drug discovery. He specializes in kinetic analysis of drug action and is known for applying binding kinetics to the development of effective therapeutics, particularly GPCR antagonists.
Before founding Pharmechanics in 2016, Dr. Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences. He guided the in vitro biology efforts of the company for numerous drug discovery campaigns. Sam is known for demystifying complicated and newly-emerging pharmacology concepts, enabling them to be applied by project teams in optimizing new molecules.
I very much enjoyed chatting with Sam about his love for GPCRs, kinetics, and decorticate the complexities of GPCR function to better target receptors.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal.
Following his Ph.D. in Neurological Sciences at the same university in 1985, he completed a post-doctoral fellow at Duke University in the laboratory of R.R. Lefkowitz. In 1989, he returned to Montréal as a professor of biochemistry and a scholar of the Medical Research Council of Canada at the Faculty of Medicine of the Université de Montréal.
Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. Dr. Bouvier is the author of 300 scientific papers and 15 patents and delivered close to 500 invited conferences. He is a world-renowned expert in the field of cell signaling and GPCRs and made seminal contributions to our understanding of this major class of drug targets. In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones, his work on bioluminescence resonance energy transfer (BRET) resulted in the development of screening assays that are now widely used for drug discovery.
His work received more than 30,000 citations yielding an h-index of 95. He has supervised the research work of 75 graduate students and 40 post-doctoral fellows. Michel’s scientific contributions were recognized by the attribution of many awards and distinctions including his election as a fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics (2017), the Wilder Penfield award from the Quebec Government (2017), the innovation award of ADRIQ (2019) and the 2021 Killam prize form the Canada Council for the Arts.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
''Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery and Optimization at Bristol-Myers, Squibb Co. in Lawrenceville, NJ. He obtained both his MS and Ph.D. in Neuroendocrine Physiology at Florida State University before completing his postdoctoral training at Northwestern University. He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility. He currently leads a team that provides mechanistic understanding of small molecule drug candidates across the entire portfolio of BMS. Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular, biochemical, cellular, and in vivo assessment of drug candidates in many different physiological systems.
Dr. Arey’s laboratory discovered the first described synthetic agonists and antagonists of the FSHR and has been an early champion of signaling bias as a physiological mechanism of gonadotropin action. He continues to pioneer in drug discovery studying GPCRs and other target classes. His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics is available on Amazon.
I sat down with Brian to chat about GPCRs, working in industry, and being a leader. This is part 2 of our conversation.''
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery and Optimization at Bristol-Myers, Squibb Co. in Lawrenceville, NJ. He obtained both his MS and Ph.D. in Neuroendocrine Physiology at Florida State University before completing his postdoctoral training at Northwestern University. He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility. He currently leads a team that provides a mechanistic understanding of small molecule drug candidates across the entire portfolio of BMS. Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular, biochemical, cellular, and in vivo assessment of drug candidates in many different physiological systems.
Dr. Arey’s laboratory discovered the first described synthetic agonists and antagonists of the FSHR and has been an early champion of signaling bias as a physiological mechanism of gonadotropin action. He continues to pioneer in drug discovery studying GPCRs and other target classes. His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics is available on Amazon.
I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. This is part 1 of our conversation.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
David Gloriam is a Professor in Computational Receptor Biology at the University of Copenhagen where he leads a research cluster for GPCR function and drug discovery and a Pharmaceutical Data Science unit. His group runs the GPCRdb database where ~4,000 researchers each month retrieve reference data and access online tools for analysis, visualization, and experiment design.
Dr. Gloriam is a corresponding member of the Nomenclature Committee of the International Union of Pharmacology (IUPHAR). He is one of the coordinators of recommendations to describe ligand bias towards signaling probes and safer drugs. His group recently developed an online resource of biased ligands and pathway effects to advance the biased signaling field.
Join me a learn more about David’s work, his career trajectory, and GPCRdb.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Dr. Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University of Cambridge (Dept of Biochemistry) to work on bacterial sugar transporters. In 2005 he started working on the development of conformational thermostabilization of GPCRs, which resulted in the structure of the β1-adrenoceptor. In 2016 mini-G proteins were developed as a tool for the structure determination of GPCRs in the fully active state. Join me to learn more about Chris’s work and his love for science.
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
http://www.drgpcr.com/consulting/
- Share your feedback with us:
http://www.drgpcr.com/audience-survey/
- Become a #DrGPCR Ecosystem Member
http://www.drgpcr.com/membership/
Dr. Pfleger trained as a pharmacologist and obtained his Ph.D. at the University of Edinburgh. I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the academic and biotech worlds.
Professor Pfleger has developed extensive expertise in profiling receptor binding and function at the molecular and cellular levels over the last 20 years, particularly involving GPCRs. He also has globally-recognized expertise in bioluminescence resonance energy transfer (BRET) technology, including his patented Receptor-Heteromer Investigation Technology (Receptor-HIT) for studying heteromers.
Kevin is also Director, Biomedical Innovation at The University of Western Australia (UWA) and the MTPConnect Western Australian Life Sciences Innovation Hub. He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry Perkins Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics Technologies, Chief Scientific Advisor to Dimerix, and co-founder of RAGE Biotech.
He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group.
Join me and learn more about Kevin’s work and how he manages all his responsibilities.
Elva is currently a research fellow at the Monash Institute of Pharmaceutical Sciences. Elva moved to Canada where she obtained her Ph.D. at the University of Western Ontario, working on the regulation of G proteins signaling by accessory proteins, such as RGS proteins and GPSM proteins. After her Ph.D., she moved to Australia and continues working on GPCRs. Her current research focuses on class B GPCRs and understanding how GPCR signaling and function is mediated by various ligands, binding partners, and intracellular machinery. In her spare time, Elva likes to run in the mountains, play with Tilly (a 9-year old retired greyhound), collecting mini shoes, and hang out with friends.
Join me to learn more about Elva, class B GPCRs, and Tilly.
Eleonora Comeo is a doctoral candidate in Medicinal Chemistry and Drug Discovery in the joint program of the University of Nottingham in the UK and Monash University in Australia. We sat down to chat about GPCRs, synthesizing labeled ligands, and her unique position that allows her to work with GPCR scientists on 2 continents. We also touched on how COVID-19 affected her Ph.D. work.
''Dr. Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Chemistry in Bethesda, MD, where he started in October 2020. He completed his postdoctoral training at MIT and Harvard Med School in the lab of Hidde Ploegh where he developed new applications of single domain antibodies (nanobodies). He earned his PhD in Chemistry at the University of Wisconsin-Madison in the lab of Sam Gellman on the study of analogs of the GPCR peptide ligand parathyroid hormone. Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and protein engineering to interrogate GPCR signaling.
Ross and I chatted about his work and his transition to an independent investigator, Join me to learn more about class B GPCRs and Dr. Cheloha’s work.''
It was December 14th, 2020, 1:50 pm, when I turned on my laptop and signed into Zoom for my chat with Bob.
Bob, who, you might ask?
Well, it’s the one and only Robert J. Lefkowitz, M.D., 2012 Nobel Prize in Chemistry, which he shared with Dr. Brian Kobilka. Bob doesn’t really need an introduction since his reputation precedes him. Before we pressed record, I asked if I could call him Bob, and he answered that only his mom used to call him Robert, especially when she was upset with him. I then pressed record, and we chatted for almost 2h about Bob’s career, discoveries, difficulties (yes, he’s had some too), Nobel week, and his memoir that he just published in collaboration with Dr. Randy Hall.
Bob is James B. Duke Professor of Medicine and Professor of Biochemistry, Chemistry, and Pathology at the Duke University Medical Center. He began his career in the late 1960s and has been an Investigator of the Howard Hughes Medical Institute since 1976. His legacy lies in the numerous discoveries he and his team made in the GPCR field and in all those who trained in his laboratory and went on to pursue stellar scientific careers.
I very much enjoyed chatting with Bob, and I hope you’ll enjoy learning more about him as well.
http://www.drgpcr.com/episode-27-dr.-robert-j-lefkowitz/
Dr. Debbie Hay is presently a professor at the Department of Pharmacology and Toxicology at the University of Otago after spending 18 years at the University of Auckland. Her work is primarily focused on class B GPCRs and their interactions with RAMPs. Debbie obtained a Ph.D. in Molecular Pharmacology from Imperial College London in the UK. She has gained experience from working in academia and at GSK as an industrial trainee.
Join me and learn more about Debbie’s career and what she learned through her experiences as a scientist.
Originally, Annette wanted to be a medical doctor but as luck has it, she didn’t get into medical school when she first applied. Instead, she discovered research and started her Ph.D. the day she should have started medical school. Dr. Gilchrist completed her Ph.D. in Biomedical Sciences / Immunology at the University of Connecticut and went on to become a postdoctoral fellow at UIC (University of Illinois at Chicago). Annette worked in industry, academia and her entrepreneurial side led her to three companies, Cue Biotech, Caden Biosciences, and MyGenomeRx in addition to being a consultant for over a decade. Dr. Gilchrist is also an associate professor at the Department of Pharmaceutical Sciences.
Join me and learn more about Annette’s career, our common love for chemokines, and how you can use your training as a scientist in so many different ways.
Dr. Niv is currently an associate professor and vice dean for research at the Hebrew University of Jerusalem. The Niv lab is also part of the Global Consortium for Chemosensory Research. Masha earned her Bachelor’s degree in chemistry, followed by a direct Ph.D. at the Institute of Chemistry, at The Hebrew University of Jerusalem in Israel. Dr. Niv trained as a postdoctoral fellow at Weill Cornell Medical College. Her work focuses on both sweet and bitter taste receptor GPCRs and her lab established the BitterDB.
Dr. Fan is currently an associate professor of Pharmacology and Pathology and Cell Biology at Columbia University in NYC. Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit signals. She obtained her bachelor's, master and doctoral degrees at Harvard University and completed her postdoctoral training with Dr. Hendrickson at Columbia University.
Join us and learn more about Qing's work and how we powered through a technical issue during the interview.
Dr. Kari Johnson is currently an assistant professor at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. She is a neuropharmacologist with an interest in the long-term effects of alcohol abuse on neural circuits. Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a postdoctoral fellow at the Vanderbilt Center for Neuroscience Drug Discovery, the National Institute of General Medical Sciences, and the National Institute on Alcohol Abuse and Alcoholism. All through her career, the recurring theme in Kari’s work has been GPCRs and more specifically Metabotropic Glutamate Receptors. Join me and learn more about how Kari studies GPCRs in basal ganglia circuits following chronic alcohol exposure in mice.
Dr. Maria Waldhoer is originally from Austria. She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology at the University of Vienna. GPCRs led Maria to Thue W. Schwartz’s lab in Copenhagen where she completed her postdoctoral training. After working in the US and at the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief Scientific Officer. Even though Maria stumbled upon the GPCR field, her 20 years in both academia and in the industry working on GPCRs make her a strong and dedicated scientific leader.
Dr. Pluznick discovered that olfactory receptors in mice are also expressed in their kidneys and blood vessels. Her research is focused on the role of chemosensory GPCRs in regulating renal and cardiovascular function, and identifying renal/cardiovascular olfactory receptor ligands, and relating them to whole-animal physiology. This work contributes to a better understanding of how the kidney helps maintain homeostasis in humans.
Jennifer is currently an assistant professor of physiology at the Johns Hopkins School of Medicine. She received her undergraduate degree in biology from Truman State University and earned her Ph.D. in renal physiology from the University of Nebraska Medical Center. She then spent five years training as a postdoctoral fellow in the laboratory of Michael Caplan at Yale University, where she studied both renal physiology and sensory biology systems and focused on olfaction.
Fiona Marshall got fascinated with GPCRs after attending a lecture on how the beta-adrenergic receptor in the heart is activated by adrenaline, during her undergraduate studies at Bath University. She then pursued her Ph.D. in neuroscience from Cambridge University. An expert in GPCR biology, Fiona published the first description of the cloning and structural requirements of the GABAB receptor. One of her career path defining moments came from when she visited Dr. Chris Tate and Dr. Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK. As a co-founder of Heptares Therapeutics, now called Sosei Heptares, a GPCR focused drug discovery and development biotechnology company, Fiona and her team made considerable breakthroughs in the field of GPCR stabilization and structure-based drug design. Today, Dr. Marshall is the VP Head of Neuroscience Discovery and Head of Discovery UK, Global Head of Neuroscience discovery research leading teams in West Point, Boston, and London at MSD. Join me and learn more about her fascinating career trajectory.
Listen to this fantastic round table discussion that I had the privilege to moderate with Alexander Hauser. Our guests were Maria Waldhoer, Tudor I. Oprea , Thomas Sakmar, Aurelien Rizk & Yaroslav Nikolaev.
The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide new opportunities to improve our understanding of human physiology and disease. In recent years, machine learning (ML) and artificial intelligence (AI) methods have received a significant boost of attention. ML/AI can be powerful for identifying abstract patterns within large data where traditional methods would be oblivious to. This comes without the need for manual feature engineering as systems can learn through implicit rules from the data provided. G protein-coupled receptors (GPCRs) mediate a vast variety of critical biological processes and provide an ideal case study for quantitative, and multi‐scale integration of these amounts of data to gain novel insights into receptor biology. How can we best leverage these exciting new techniques in areas such as protein structure prediction, bioactive ligand discovery, in vivo translationability or in our understanding of signalling determinants? Here, we would like to discuss opportunities, weaknesses, and advantages of these new technologies, which may contribute to probe our favorite targets at all scales.4- Banner photo:
GPCRs have played a central role in my scientific career ever since I took Dr. Michel Bouvier’s class as an undergraduate student at the University of Montreal in early 2000. During the past 2 decades, my research mainly focused on chemokine receptor structure/function relationships. For the purposes of this presentation, I will walk you through my various career experiences and include the skills I learned during each experience, which ultimately led me to found Dr.GPCR. Last, I will give an overview of the various programs we established at DR.GPCR, present our team as well as provide you with a sneak peek of our future podcast guests and more.
In this episode of the Dr. GPCR Podcast, I spoke to Dr. Aaron Sato from Twist Biopharma, a vertical within Twist Bioscience. Aaron is currently the Chief Scientific Officer and VP of Protein Engineering. He earned his Ph.D. at the Massachusetts Institute of Technology where he studied MHC class II structure-function relationships. His path led him to work in an industry where he assumed various responsibilities and roles in the antibody space. Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics. Dr. Sato published over 30 peer-reviewed papers and contributed to 40 issued patents in the antibody space.
During our time together, Aaron and I discussed how using Twist Bioscience’s proprietary technology to manufacture DNA at a scale, the team saw an opportunity to tackle the challenge of identifying novel functional antibodies targeting GPCRs by incorporating these natural binding partners into Twist’s antibody library design.
We’d like to extend a special thanks to Twist Biopharma for sponsoring this episode of the Dr. GPCR podcast.
In this episode of the Dr.GPCR podcast, my guest is Dr. Arun Shukla from the Indian Institute of Technology in Kanpur, India. Arun is currently an Associate Professor & Joy Gill Chair Professor, Intermediate Fellow, Wellcome Trust DBT India Alliance
Swarnajayanti Fellow & EMBO Young Investigator at the Department of Biological Sciences and Bioengineering. He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during a biochemistry class where he learned about cell signaling that he became curious and wanted to learn more about it. Arun first started working on GPCRs and their structural characterization at the Max Planck Institute of Biophysics where he completed his doctoral studies in the lab of Dr. Hartmut Michel.
Fascinated by GPCRs he wrote to Dr. Bob Lefkowitz and asked him if he could join his lab at Duke University. Dr. Shukla spent several years in the Lefkowitz lab and collaborated extensively with Dr. Brian Kolbika of Stanford University.
Join us and learn more about Dr. Shukla’s research and how working in the lab instead of going to classes made him realize that research is what he wants to do for the rest of his life.
Dr. Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Chapel Hill School of Medicine. After receiving his MD and Ph.D. in Biochemistry from St. Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry at Stanford. Bryan leads a $26.9 Million project to create better psychiatric medications among other things.
But, it wasn’t always this way. Bryan got fascinated with receptors after attending the lecture of a visiting professor on neurotransmission while in college in Montana, where he is from. He was determined to work on psychiatric disorders and persevered even when he was told several times he would never make it as a basic scientist and that he would never publish anything important. Join me and learn more about Bryan and his work.
In this episode of the Dr. GPCR podcast, we meet with Dr. Amynah Pradhan. She is an Associate Professor of Psychiatry at the University of Illinois at Chicago. Amynah did her undergrad research measuring IP3 in airway smooth muscle cells and completed a Ph.D. at McGill University in Canada with Dr. Paul Clarck where she studied opioid receptors. Her next career step took her to AstraZeneca as a postdoctoral trainee where she studies animal models of pain and sensory neuron sensitive-receptor. She then moved back to academia and worked on opioids as a postdoctoral trainee with Dr. Brigitte Kieffer where she studied ligand directed signaling at the delta-opioid receptor. Her career path defining moment came from a third postdoctoral experience with Dr.Chris Evans at UCLA. Amynah studied how arrestins regulate ligand directed signaling at delta-opioid receptors and it is the collaboration with a headache physician-scientist Dr. Andrew Charles that she specialized in animal models of migraine and delta-opioid receptors as a therapeutic target to treat a headache.
In this episode of the Dr. GPCR podcast, we meet with Dr. Antonella Di Pizio, an independent research group leader at the Leibniz-Institute for Food Systems Biology at the Technical University of Munich. Antonella trained as a medicinal chemist in Italy, which she followed up by a Ph.D. in computational medicinal chemistry, during which she developed a taste for structural biology. Antonella then moved to Israel, where she first started working on bitter taste GPCRs in Dr. Masha Niv's lab. Today, Antonella has expanded her research to olfactory GPCRs and trace amine receptors. Join us to learn more about chemosensory GPCRs and how computational pharmacology can help better understand their function.
In this special episode of the Dr.GPCR podcast, I sat down with the co-founders of Genemod. Jacob Lee and Jin Choe met in ninth grade in English class and have been friends since. Although both went to the same college, Jacob and Jin choose different career paths. One day as they were catching up, Jacob shared his struggles of managing samples and an incredible amount of data and projects in the lab with Jin. Our of this need Genemod was born. Today, Genemod has built a freezer management tool and a project management tool where scientists can manage their reagents, samples, and projects on one intuitive platform. The team is planning on building even more tools that will make Genemod the go-to platform for all research scientists to make research more efficient.
Our guest in this episode of the Dr.GPCR podcast is Dr. John Streicher from the department of pharmacology at the University of Arizona. John started grad school in 1999 and spent some time figuring out what he was interested in. It turns out that it was signal transduction and he worked on the signaling cascades involved in heart failure. His encounter and interest in signaling in the context of GPCRs during his postdoctoral training in Dr. Laura Bohn’s lab at Scripps Research Institute in Florida. Today, John and his team focus on understanding how signal transduction cascades downstream of the opioid receptors work.
In this special Dr. GPCR podcast episode, we sat down to chat with Lauren Celano to talk about career options for Ph.D.’s. Working in a lab allows scientists to gain amazing hard and soft skills, which opens the doors to a number of great careers, that many have not even considered, yet. Lauren has a science background and is passionate about helping talented scientists find their dream position. She is also a speaker, connector, recruiter, and coach.
Dr. Graciela Pineyro is a professor of pharmacology at the department of pharmacology and physiology of the University of Montreal. She has done extensive work on the molecular pharmacology of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain. We chatted about how the current pandemic has affected her personally and professionally.
Dr. Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San Diego. Paul thinks broadly about science and has been actively publishing papers about his ideas on how COVID symptoms could be treated while we wait for a vaccine, particularly about ACE2 and angiotensin. For the past 30 years, he has been the Director of MD/Ph.D. training program at UCSD and has served as Editor or Senior Editor of numerous scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology, British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.
Dr. J. Silvio Gutkind sheds light on his work and life since the beginning of COVID restrictions. Dr. J. Silvio Gutkind is a Professor of Pharmacology based at UCSD School of Medicine. A large component of his work is centered around dysregulated signaling in cancer and the development of novel mechanism-based cancer therapies. In this episode, Dr. J. Silvio Gutkind highlights how his past experience proves useful in current COVID times and potential benefits the changes in work environments can do for future collaborations.
Dr. Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University. Much of his work is based around GPCR signaling in context to cardiovascular diseases. In this special episode of the Dr.GPCR podcast, we re-connected with Dr.Terry Hebert to chat about how he and his team has been adapting to the new reality of working remotely. Terry tells us about the importance of adapting, communication, and being mindful of those around us.
Dr. Graciela Pineyro’s love for GPCR pharmacology started in Uruguay where she first worked on the serotonin receptors. This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived for her Ph.D. work. Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling, trafficking, and their ability to activate different signaling pathways and signaling bias. Today, Graciela and her team’s efforts are directed towards the characterization of the pharmacological properties of cannabinoids in conjunction with terpenes for pain relief.
Have you had moments that defined your scientific tastes? For Dr. J Silvio Gutkind, a class on oncogenes and his interests for GPCRs helped shape his scientific interests. These took him from the University of Buenos Aires in Argentina to UC San Diego and through the National Institutes of Health in Bethesda, Maryland. In this episode, Silvio discusses G protein signaling in the context of cancer, immunotherapies, and combination therapies that could help improve patients’ lives.
Dr. Terry Hebert wanted to be a microbiologist. Instead, he ended up getting interested in membrane protein as he followed the biology of a bacterial toxin that affects a mammalian ion channel. Today he and his team are working on understanding receptor signaling in specialized cellular environments to gain a better grasp of receptor function in pathophysiological settings with a special interest in the cardiovascular system. His favorite GPCR is the angiotensin 1 receptor especially for its ability to activate a large variety of signaling pathways. Terry is also very active on social media. With over 2000 followers on Facebook and Twitter, he shares the latest available information on GPCR research daily.
In 1975, Dr. Paul Insel was at the FASEB experimental biology meeting in Atlantic City. During dinner with colleagues and Alfred Gillman, co-recipient of the 1994 Nobel Prize in Physiology or Medicine for their discovery of G-proteins and their role in signal transduction in cells, Paul was designated to go to Gillman’s lab. That summer, he used radioligand binding methods to dissect receptor function from the adenylyl cyclase activated by ligands, including adrenaline. From that point on, Paul was hooked and has since studied receptor function in human physiology, receptor molecular pharmacology in cells, and animal models, and as he puts it has now he’s ‘’gone full circle’’ back to studying GPCRs important in human pathophysiology. Today, Paul and his team focus on previously unrecognized receptors with the hopes to use these as novel drug targets.
In this Episode 0 of the podcast, I, Dr. Yamina Bechiche, your host, and founder of DrGPCR introduce you to the very first podcast dedicated to GPCR researchers and their work. This podcast is part of the Dr. GPCR Ecosystem. The goal is to bring us together GPCR scientists, biotech, and pharma leaders as well as suppliers working on GPCRs. We want to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together to accelerate GPCR drug discovery and improve human health.
For more information visit us at DrGPCR.com/Podcast and join the DrGPCR Ecosystem at DrGPCR.com/Ecosystem. Don't forget to subscribe to our monthly newsletter at DrGPCR.com/Newsletter.